ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,511,002 | -45.1% | 195,599 | -37.9% | 0.12% | -36.5% |
| Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
| Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
| Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
| Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
| Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
| Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
| Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
| Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |